Trials / Completed
CompletedNCT01656720
A Multi-centre, Phase II, Double-blind, Randomised, Placebo-controlled, Parallel Group, Dose-ranging Study in Patients With Faecal Incontinence; to Evaluate the Efficacy, Safety and Tolerability of Locally Applied NRL001 Over an 8 Week Treatment Period
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 417 (actual)
- Sponsor
- Norgine · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety, tolerability and efficacy of NRL001 in the treatment of faecal incontinence, compared against placebo
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 1R, 2S-methoxamine hydrochloride | |
| DRUG | Placebo |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2013-12-01
- Completion
- 2014-09-01
- First posted
- 2012-08-03
- Last updated
- 2015-06-09
Locations
51 sites across 9 countries: Czechia, France, Germany, Hungary, Italy, Poland, Spain, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT01656720. Inclusion in this directory is not an endorsement.